Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline retrospective case report in pediatric CONDSIAS
IRCT20250624066242N7Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minocycline in stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (CONDSIAS), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Neurological regression status, Motor function and 1 more. Started Jul 2025; status: completed.
02
Drugs
minocycline
03
Conditions
stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (CONDSIAS)
Beyond the preview
Go deeper on IRCT20250624066242N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250624066242N7.